Fisher Asset Management
COGT icon

Fisher Asset Management’s Cogent Biosciences COGT Stock Holding History

Fisher Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.15M Buy
184,875
+17,463
+10% +$611K ﹤0.01% 442
2026
Q1 		$6.44M Buy
167,412
+119,498
+249% +$4.41M ﹤0.01% 441
2025
Q4 		$1.7M Sell
47,914
-55,578
-54% -$1.56M ﹤0.01% 584
2025
Q3 		$1.49M Sell
103,492
-7,416
-7% -$87.9K ﹤0.01% 629
2025
Q2 		$796K Hold
110,908
– – ﹤0.01% 721
2025
Q1 		$664K Hold
110,908
– – ﹤0.01% 747
2024
Q4 		$865K Sell
110,908
-18,507
-14% -$184K ﹤0.01% 678
2024
Q3 		$1.4M Sell
129,415
-19,630
-13% -$191K ﹤0.01% 624
2024
Q2 		$1.26M Buy
149,045
+47,514
+47% +$360K ﹤0.01% 647
2024
Q1 		$682K Sell
101,531
-260
-0.3% -$1.61K ﹤0.01% 734
2023
Q4 		$599K Buy
101,791
+33,222
+48% +$255K ﹤0.01% 751
2023
Q3 		$669K Hold
68,569
– – ﹤0.01% 808
2023
Q2 		$812K Hold
68,569
– – ﹤0.01% 815
2023
Q1 		$740K Hold
68,569
– – ﹤0.01% 804
2022
Q4 		$793K Hold
68,569
– – ﹤0.01% 798
2022
Q3 		$1.02M Buy
+68,569
New +$940K ﹤0.01% 662

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management's COGT Position: Q2 2026 in Review

Fisher Asset Management increased its Cogent Biosciences (COGT) stake by 10% in Q2 2026, buying an estimated $611K and bringing the position to 184,875 shares worth $7.15M. The position accounts for ﹤0.01% of the portfolio, ranked #442.

Fisher Asset Management first reported a position in COGT in Q3 2022 and has held it in 16 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Fisher Asset Management held 184,875 shares of Cogent Biosciences worth $7.15M as of Q2 2026.
  • Fisher Asset Management bought 17,463 Cogent Biosciences shares in Q2 2026, an estimated $611K.
  • Cogent Biosciences made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #442 holding.
  • Fisher Asset Management first reported a position in Cogent Biosciences in Q3 2022 and has held it in 16 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.